MedPath

Fear of Cancer Recurrence in Genitourinary Cancer

Completed
Conditions
Prostate Cancer
Urothelial Carcinoma
Testicle Cancer
Fear of Cancer Recurrence
Renal Cell Cancer
Registration Number
NCT04535921
Lead Sponsor
Ludwig-Maximilians - University of Munich
Brief Summary

To perform an analysis of independent predictors of fear of cancer recurrence in patients with malignant genitourinary diseases and their impact on quality of life and survival

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • histologically confirmed diagnosis of either prostate, urothelial cell, testicular or renal cell cancer
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in fear of cancer recurrence pre- and postoperatively7 to 10 days after initial surgery

Changes in the FCR7 score pre- and postoperatively

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ludwig-Maximilian-Universität

🇩🇪

Munich, Bavaria, Germany

Ludwig-Maximilian-Universität
🇩🇪Munich, Bavaria, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.